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Abstract
Background: Resuscitation promoting factors (RPF) are secreted proteins involved in reactivation of dormant actinobacteria,
including Mycobacterium tuberculosis. They have been considered as prospective targets for the development of new anti-
tuberculosis drugs preventing reactivation of dormant tubercle bacilli, generally associated with latent tuberculosis.
However, no inhibitors of Rpf activity have been reported so far. The goal of this study was to find low molecular weight
compounds inhibiting the enzymatic and biological activities of Rpfs.
Methodology/Principal Findings: Here we describe a novel class of 2-nitrophenylthiocyanates (NPT) compounds that
inhibit muralytic activity of Rpfs with IC50 1–7 mg/ml. Fluorescence studies revealed interaction of active NPTs with the
internal regions of the Rpf molecule. Candidate inhibitors of Rpf enzymatic activity showed a bacteriostatic effect on growth
of Micrococcus luteus (in which Rpf is essential for growth protein) at concentrations close to IC50. The candidate compounds
suppressed resuscitation of dormant (‘‘non-culturable’’) cells of M. smegmatis at 1 mg/ml or delayed resuscitation of dormant
M. tuberculosis obtained in laboratory conditions at 10 mg/ml. However, they did not inhibit growth of active mycobacteria
under these concentrations.
Conclusions/Significance: NPT are the first example of low molecular weight compounds that inhibit the enzymatic and
biological activities of Rpf proteins.
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Introduction
Tuberculosis (TB) still kills millions of people around the Globe.
Moreover, Mycobacterium tuberculosis has been suggested to persist in
a dormant state in approximately 2 billion of people [1] (Dormancy
is a reversible physiological state of the bacteria characterized by
low metabolic activity, in which cells can persist for extended
periods without division). Due to reasons that are not fully clear,
such latent infection can reactivate at any time causing active
tuberculosis [2] (Latency is a clinical state of asymptomatic, chronic
infection). Importantly, dormant mycobacteria are less susceptible
to antibiotics which are normally used for treatment of active
tuberculosis. Therefore, finding of new compounds with potential
activity against latent forms of tuberculosis is an urgent task for the
scientific community. Ideally, such compounds should sterilize
dormant M. tuberculosis in the host environment or block its
reactivation.
The discovery of Rpfs (resuscitation promoting factor), a family
of proteins involved in the control of dormancy and ‘‘non-
culturability’’ of mycobacteria and related organisms, has provided
a promising opportunity to explore new strategies on targeting M.
tuberculosis persistent organisms associated with latent infections. M.
tuberculosis contains five rpf-like genes which products, RpfA-E
expressed as recombinant proteins in E. coli stimulated replication
and resuscitation of mycobacterial cells [3,4]. The importance of
the Rpf proteins for resuscitation of dormant (‘‘non-culturable’’)
M. tuberculosis cells in vitro and for growth of viable cells in vivo was
also confirmed in the study of the Rpf knockout mutants
[5,6].Despite these mutants were defective for reactivation from
chronic tuberculosis [7,8] the possible significance of Rpfs for
establishing and maintenance of latent tuberculosis has yet to be
clarified. Therefore, Rpfs represent attractive targets for develop-
ment of new drugs preventing resuscitation of dormant M.
tuberculosis. Such drugs will have a great potential for prophylaxis of
latent TB reactivation, provoked by the application of anti-TNF
antibodies therapy [9]. However, until recently, no substances
inhibiting the biological activity of Rpf have been reported.
Despite the progress in the Rpf research, the mechanisms of its
biological activity remain unclear. Recent findings suggest that
Rpfs are probably involved in the remodelling of bacterial cell
envelope [10,11,12]. According to NMR [13] and X – ray
diffraction [14] studies of the conserved domain of Rpf is
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is more similar to lytic transglycosylases [12]. Several experimental
results confirmed that Rpf possesses cell wall hydrolysing activity.
Moreover, a correlation between this enzymatic activity and the
resuscitation activity of Rpf has been found [15]. In particular, the
ability of recombinant Rpf protein to hydrolyze the artificial
lysozyme substrate, 4-methylumbelliferyl-b-D-N,N9,N0-triacetyl-
chitotrioside (4-MUF-3-NAG) [15,16] opened a possibility for the
fast screening of low molecular weight compounds which could
serve as inhibitors of the Rpf proteins. In this paper we report on
several nitrophenylthiocyanates (NPT) with anti-Rpf activity.
Materials and Methods
Chemistry
Melting points were determined according to the BP procedure
and are uncorrected (Electrothermal 9001, GB). If analyses are
indicated only by the symbols of the elements, analytical results are
within 6 0.3% of the theoretical values (Carlo-Erba 5500, Italy).
NMR spectra were determined with a Varian Unity Plus 400
(USA). Shifts for
1H NMR are reported in ppm downfield from
TMS (s). Mass spectra were obtained using a Finnigan SSQ-700
(USA) instrument with direct inject. Silicagel 60 F254 aluminium
sheets (Merck Co, Germany) were used for all analytical thin layer
chromatography (TLC). All chemicals were purchased from Alfa
Chemicals (Lancashire, England) including starting otho-chloroni-
troaryles for synthesis target compounds (III), (IV), (V), (VI), (VIII),
(IX), (X).
4-chloro-6-methoxy-5-nitropyrimidine was synthesised accord-
ing to [17].
General procedure for 2-thiocyanatonitroaryles synthesis
(Figure 1). A suspension of 2-chloronitroaryles (4.00 mmol) and
1,5-dichloroantraquinone (3 mg, 0.011 mmol) in ethanol (25 ml)
was treated by 10 ml ethanol solution of KSCN (0.58 g,
6.00 mmol) and heated at 50uC for 2–6 h. After cooling the
reaction mixture was dissolved in 100 ml of cold water and
light yellow precipitate was collected by filtration. The solid
residue was twice crystallised from suitable solvent to obtain 2-
thiocyanatonitroaryles with .96% purity (yield 35–55%).
4-Methoxy-5-nitro-6-thiocyanatopyrimidine (I). Suspension
of 1.94 g (1.0 mmol) of 4,6-dichloro-5-nitropyrimidine in 20 ml
methanol was treated by methanol solution of MeONa (prepared
in advance from 0.23 g (1.0 mmol) of natrium and 10 ml of
methanol) at 0uC. Reaction mixture was stored for 2 h at room
temperature and mixed with 100 ml of cold water. White crystalline
solid of 4-chloro-6-methoxy-5-nitropyrimidine was filtered off and
crystallised from ethanol (mp. 54–56uC). Follow reaction according
‘‘General procedure for 2-thiocyanatonitroaryles synthesis’’ leads to
the target compound (I). Mp 128–31uC (ethanol). m/z
+. 212.
1H
NMR (DMSO) s 9.25 (1H, s, CH) and 4.17 (3H, s, CH3). Anal.
(C6H4N4O3S), C,H,N,S.
4-Isopropylamino-5-nitro-6-thiocyanatopyrimidine (II).
Solution of 1.94 g (1.0 mmol) of 4,6-dichloro-5-nitropyrimidine
in 20 ml dioxane was treated by water solution of isopropyl-
amine acetate (prepared in advance from 1.20 g (2.0 mmol)
of isopropylamine and excess of acetic acid in 5 ml of water).
Figure 1. Schematic representation of 2-thiocyanatonitroaryles (I)–(X) synthesis.
doi:10.1371/journal.pone.0008174.g001
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and mixed with 100 ml of cold water. Light yellow crystalline
solid of 4-chloro-6-isopropylamine-5-nitropyrimidine was filtered
out and crystallised from ethanol (mp. 96–98uC). Follow reaction
according ‘‘General procedure for 2-thiocyanatonitroaryles
synthesis’’ leads to the target compound (II). Mp 143–5uC
(ethanol). m/z
+. 239.
1H NMR (DMSO) s 8.43 (1H, s, CH), 4.86
(1H, m, CH(CH3)2) and 1.37 (6H, s, 2CH3). Anal. (C8H9N5O2S),
C,H,N,S.
1,5-Dinitro-2,4-dithiocyanatobenzene (III). Usage of 1,5-
dinitro-2,4-dichlorobenzene according ‘‘General procedure for 2-
thiocyanatonitroaryles synthesis’’ leads to the target compound
(III). Mp 78-80uC (DMF/water). m/z
+. 282.
1H NMR (DMSO) s
9.66 (1H, s, CH) and 8.61 (1H, s, CH). Anal. (C8H2N4O4S3),
C,H,N,S.
2-Nitro-4-(trifluoromethyl)-phenylthiocyanate (IV). Usage
4-chloro-3-nitrobenzotrifluoride according ‘‘General procedure for
2-thiocyanatonitroaryles synthesis’’ leads to the target compound
(IV). Mp 78–81uC (ethanol). m/z
+. 248.
1H NMR (DMSO) s 8.51
(1H, s, CH), 8.29 (1H, d, CH) and 7.84 (1H, d, CH). Anal.
(C8H3F3N2O2S), C,H,N,S.
3-Nitro-4-thiocyanobenzonitryl (V). Usage 4-chloro-3-nitro-
benzonitrile according ‘‘General procedure for 2-thiocyanato-
nitroaryles synthesis’’ leads to the target compound (V). Mp 143-5uC
(ethanol). m/z
+. 205.
1H NMR (DMSO) s 8.40 (1H, s, CH), 8.26
(1H, d, CH) and 7.90 (1H, d, CH). Anal. (C8H3N3O2S), C,H,N,S.
4-Acetyl-2-nitrophenyl thiocyanate (VI). Usage 49-chloro-
39-nitroacetophenone according ‘‘General procedure for 2-
thiocyanatonitroaryles synthesis’’ leads to the target compound
(VI). Mp 96-8uC (ethanol). m/z
+. 222.
1H NMR (DMSO) s 8.69
(1H, s, CH), 8.09 (1H, d, CH), 7.85 (1H, d, CH) and 2.57 (3H, s,
CH3). Anal. (C9H6N2O3S), C,H,N,S.
4-Benzoyl-2-nitrophenyl thiocyanate (VII). Solution of
4.35 g (2.0 mmol) 4-chlorobenzophenone in 6 ml of sulfuric acid
was treated by mixture of 2 ml of nitric acid and 2 ml of sulfuric
acid at 0uC. Reaction mixture was warmed up to the room
temperature, heated at 65uC for 2 h and put on 100 g of crashed
ice. White solid of 4-chloro-3-nitrobenzophenone was collected,
dried and crystallized from hexane (mp 104–6uC). Follow reaction
according ‘‘General procedure for 2-thiocyanatonitroaryles
synthesis’’ leads to the target compound (VII). Mp 132–5uC
(ethyl acetate). m/z
+. 284.
1H NMR (DMSO) s 8.58 (1H, s, CH),
8.11 (1H, d, CH), 7.93 (1H, d, CH), 7.67 and 7.41 (5H, m, C6H5).
Anal. (C14H8N2O3S), C,H,N,S.
3-Nitro-4-thiocyanatobenzoic acid (VIII). Usage 4-chloro-
3-nitrobenzoic acid according ‘‘General procedure for 2-
thiocyanatonitroaryles synthesis’’ leads to the target compound
(VIII). mp 220-4uC (ethanol/water). m/z
+. 224.
1H NMR
(DMSO) s 8.56 (1H, s, CH), 8.18 (1H, d, CH) and 7.87 (1H, d,
CH). Anal. (C8H4N2O4S), C,H,N,S.
3-Nitro-4-thiocyanatobenzoic acid methyl ester (IX) and 3-nitro-4-
thiocyanatobenzoic acid ethyl ester (X) were synthesized according [18].
The physico-chemical properties of compounds (IX) and (X) were
identical to the reported ones.
Bacterial Growth
Micrococcus luteus, Fleming strain 2665, NCIMB13267 was grown
in Nutrient Broth (Hi Media) on an orbital shaker at 30uC.
Mycobacterium smegmatis mc
2155 was grown in Sauton’s medium on
an orbital shaker at 37uC. M. tuberculosis H37Rv was grown under
agitation at 37uC (200 rpm), in Sauton’s medium supplemented by
ADC with 0.05% w/v Tween 80 [19] or in 7H9 liquid
supplemented with 10% v/v of OADC (BD) and 0.05% w/v of
Tween 80. Specially modified media (see below) were applied for
generation of ‘‘non-cultutrable’’ mycobacteria.
MIC Determination
Cells of M. luteus were grown to the stationary phase in the rich
medium (NB, Himedia) for 48 h. Cultures were washed twice by
centrifugation and diluted to 10
5 cells/ml by the same medium.
Diluted cells were distributed on 96 well plates (250 ml per well)
and incubated in the Multiskan Analyzer (Thermo, Finland) with
620 nm filter at 30uC for 24 h with shaking. Prior the incubation,
the inhibitors, freshly dissolved in DMSO (1 mg/ml), were added
in 0.5–10 mg/ml concentration range to the appropriate wells in
triplicates. The culture of M. luteus without inhibitors served as a
control. Bacterial growth was followed by measurement of optical
density at 620 nm. Cells of M. smegmatis grew in NB medium to the
stationary phase for 24–26 h and were diluted to 10
5 cells/ml by
the same medium containing 0.05% w/v Tween-80. Cell growth
with and without inhibitors was detected at 37uC in the Multiskan
Analyzer, similarly to M. luteus experimental conditions. M.
tuberculosis grew in Sauton’s medium supplemented by ADC in
the presence of 0.05% Tween-80 for 8 days. Cells were inoculated
in 2 ml of fresh medium at ca 10
6 cells/ml in test tubes. Inhibitors
were added at 1-25 mg/ml in triplicates. Test tubes were incubated
without shaking at 37uCO D 600 was measured periodically, using
Eppendopf Biophotometer for 14 days.
Formation of ‘‘Non-Culturable’’ Cells of M. smegmatis
and M. tuberculosis
M. smegmatis mc
2155 harbouring the pAGR plasmid with the rpf
gene was used to produce ‘‘non-culturable’’ (NC) cells in the
stationary phase as described previously [20]. M. tuberculosis ‘‘non-
culturable’’ cells [21] were established after the prolonged storage
(4–5 months) of stationary cultures after cell growth in the
modified Sauton’s medium without K
+ for 50 days [22].
Resuscitation of ‘‘Non-Culturable’’ Cells of M. smegmatis
and M. tuberculosis
Resuscitation and most probable number (MPN) assays of M.
smegmatis were performed in 48-well plastic plates (Corning)
containing 1 ml of Sauton’s medium diluted 1:1 with 0,6% (w/
v) glycerol in water. Some wells contained inhibitors at 0.1–25 mg/
ml. All wells were supplemented with 0.05%(w/v) yeast extract
(LabM). Appropriate serial dilutions of the starved M. smegmatis
cells (100 ml) were added to each well. Plates were incubated at
37uC with agitation at 150 rpm for 10–14 days. Wells with visible
bacterial growth were counted as positive, and MPN values were
calculated using standard statistical methods [23]. The identity of
cells was verified by microscopy using a Nikon microscope (Japan).
Similar procedure was applied for resuscitation of M. tuberculosis
cells, save that the diluted Sauton’s medium was supplemented by
10% v/v ADC, and cell dilutions were prepared in screw capped
test tubes which were kept standing at 37uC for 2 months.
Isolating and Purification of Recombinant Rpf Proteins
The truncated form of M.luteus Rpf (RpfSm) was used for the
analysis. The truncated protein contained conserved Rpf domain
and additional 20 amino acids of the gene product, corresponding
to the following amino acid sequence:
ATVDTWDRLAECESNGTWDINTGNGFYGGVQFTLSS-
WQAVGGEGYPHQASKAEQIKRAEILQDLQGWGAWPLCS-
QKLGLTQADADAGDVDATE. The truncated gene was ampli-
fied by PCR from the pET-19b-Rpf described before [24], using a
T7 promoter primer CGCGAAATTAATACGACTCACTAT
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CACGT (BamH1 restriction cite is underlined). After denatur-
ation for 5 min at 94uC, samples were subjected to 2 cycles of: 30 s
at 94uC, 30 s at 58uC, 60 s at 72uC, followed by 2 cycles of: 30 s at
94uC, 30 s at 56uC, 60 s at 72uC and 25 cycles of: 30 s at 94uC,
30 s at 54uC, 60 s at 72uC, followed by 5 min at 72uC. The
purified PCR product was digested with XbaI and BamH1,
purified, ligated into pET19b vector and established in E. coli
DH5a. The construct containing the truncated rpf gene (RpfSm)
was sequenced and transformed in E. coli HSM174 (DE3). RpfSm
was purified from 350 ml cultures of the E. coli producer strain,
grown at 37uC in the rich medium (Hi Media) containing 100 mg/
ml ampicillin to optical density OD600 nm 0.65–0.8. After
induction with 1 mM IPTG, growth continued for 2 h at room
temperature. Cells were collected by centrifugation at 3000 g for
15 min and frozen in the binding buffer (BB) (20 mM Tris-HCl
pH 8.0; 0.5 M NaCl; 5 mM imidazole). After thawing out,
RNAase and DNAase, both at concentrations of 10 mg/ml were
added in the presence of 10 MM MgSO4, followed by addition of
8 M urea. After sonication, the crude extract was centrifuged at
6000 g for 30 min to remove cell debris, and supernatant was
applied to the Ni
2+-chelation column (V=2 ml) («Sigma»,
Germany), equilibrated with BB. The Biological LP system
(«Biorad») was employed for the elution and refolding of the
protein on the Ni-NTA column: first, the series of washing steps,
with the BB contained 8 M urea, were applied. The second
(refolding step) was the application of BB with urea concentration
declining linearly from 8 M to zero. The protein was eluted by
linear gradient of imidazole from 5 mM to 500 mM. Protein was
collected in the range of imidazole concentrations of ,250 mM in
a total volume of 4–5 ml. Dialysis of Rpf contained fraction (30–
50 mg/ml) was performed against 50 mM citric acid-sodium
citrate buffer, pH 6.0. The protein was stored at +4uC for one
week without significant loss of the activity.
DDUFRpfB was expressed and purified under native conditions
according to [25] save that incubation with IPTG was 2 h at room
temperature. Final concentration of the protein was 150–250 mg/
ml. Dialysis step and storage were similar to RpfSm.
Muralytic Activity of Rpf
To determine a muralytic activity of the recombinant Rpfs’, 4-
methylumbelliferyl-b-D-N, N9,N 0-triacetylchitotrioside (4-MUF-
3-NAG) (‘‘Sigma’’, Germany) was applied. 6 mM of 4-MUF-3-
NAG was mixed with the proteins (1–10 mg/ml) in 100 mM citric
acid-sodium citrate buffer, pH 6.0 with 0.5 mM MgSO4 in total
volume of 0.4 ml. A number of experiments were performed in the
presence of NPT compounds, in concentration range of 0.5–
10 mg/ml. After 3 hours of incubation at 37uC, 2 mlo f1 0M
NaOH was added and the samples were frozen and kept at
220uC. The kinetic analysis of Rpf activity and inhibition was
performed using the range of concentrations of the substrate from
3t o2 4mM and the inhibitor (VII) from 0.5 to10 mg/ml. The
intensity of fluorescence was detected by the RF-5301PC
fluorimeter (‘‘SHIMADZU’’, Japan) using excitation wavelength
of 364 nm and a read-out of 448 nm.
CD Spectra
CD analysis of Rpf proteins was performed in a buffer 220 mM
phosphate, 50 mM sodium chloride, pH 7.0. The traces of
imidazole in the protein were removed by extensive dialysis prior
to the CD spectra recording. Measurements were performed using
Jasco – 720 automatic recording spectrophotometer; 1 mm path
length quvette was used; slit width 1.5 nm; time constant 3 sec.
Experiment was performed at 20uC. Inhibitors were used as
acetonitrile solution (1 mg/ml).
Fluorescence Quenching Measurements
The steady-state fluorescence excitation and emission spectra of
DDUFRpf B were recorded at room temperature using the RF-
5301PC fluorimeter (‘‘SHIMADZU’’, Japan) in 0.361 cm path
length quartz quvette with slit width 1.5 nm for excitation and
3 nm for emission channels. Proteins (40–50 mg/ml) were
dissolved in 50 mM phosphate buffer, pH 7.5. The fluorescence
emission spectra were measured under excitation wavelength at
280 nm. Fluorescence quenching measurements were analysed
using the Stern-Volmer equation [26]:
F0
F
~1zKq Q ½  , ð1Þ
and the modified form of the equation for the heterogeneous type
of quenching:
Fo
DF
~
1
faKa Q ½ 
z
1
fa
ð2Þ
where F0 and F are the relative fluorescence intensities in the
absence and presence of quencher, respectively, [Q]- concentra-
tion of quencher and Kq is the Stern – Volmer quenching constant.
Results
Enzymatic Activity of Rpf Is Inhibited by NPT Compounds
Hydrolytic enzymes play a key role for spore germination in
many microorganisms [27,28]. Recently synthesized a family of
nitrophenylthiocyanates (NPT), which strongly suppressed germi-
nation of fungal spores (unpublished results ) and therefore could
be considered as promising inhibitors of cell wall hydrolases,
including lytic transglycosylases, a class of enzymes structurally
similar to Rpf which are known to be first activated during
endospore germination [27] and chitinase involved in fungi spore
germination [28]. Therefore, the effect of the influence the NPT
compounds (Figure 1) on the enzymatic and biological activities of
Rpfs was studied. We first tested the effect of compounds on Rpf
muralytic activity judging by the hydrolysis of the artificial
fluorogenic substrate, 4-MUF-3-NAG, previously applied to
analyze the activity of the recombinant Rpf of M. luteus [15].
The Rpf proteins are generally very unstable and inactivate soon
after purification [15]. To solve this problem we used two different
recombinant Rpf proteins that possess higher stability, solubility
and retain activity for longer period of time. Firstly, a truncated
form of M. luteus Rpf lacking the last 89 amino acid residues of the
C-terminal part (Rpf Sm) and secondly, recently described
truncated form of Rpf B (DDUF RpfB) [14]. Both proteins were
able to hydrolyze 4-MUF-3-NAG with the maximum specific
activity at 7.663.3 nmol/mg?h and 2.561.4 nmol/mg?h for
RpfSm and DDUFRpfB correspondingly. We found that four out
of five of the initially tested compounds (I)-(IV) and (IX) inhibited
muralytic activities of both proteins in the 1–7 mg/ml concentra-
tion range (Table 1). The most potent compound for DDUFRpfB,
(IX), was used for synthesis of derivative compounds (V-VIII, X).
Apart of negatively charged compound (VIII), the derivative
compounds displayed inhibitory activity on the Rpf- mediated
MUF-3-NAG hydrolysis (VIII) (Table 1). The Lineweaver-Burk
plot revealed non-competitive inhibition of Rpf-Sm muralytic
activity by the compound (VII) (Figure S1).
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To exclude possible alterations of the Rpf secondary structure
caused by NPT, CD measurement studies were undertaken using
both Rpfs. Figure S2 A, B shows that the addition of the inhibitor
(VII) did not produce significant changes in the CD spectra.
Interaction of NPT Compounds with Rpf (Fluorescence
Quenching Analysis)
The existence of several tryptophanes and phenylalanines
residues in the Rpf molecule enables one to analyse an interaction
between NPTs and Rpf by fluorescence quenching. The addition
of the highly efficient inhibitor of the enzymatic activity of Rpf, the
compound (VII), to DDUFRpfB resulted in significant quenching of
its auto-fluorescence (excitation 280 and emission 340) (Figure 2A).
Application of the standard Stern-Volmer equation, (1) clearly
showed a heterogeneous type of quenching with different
accessibility of tryptophan residues for the inhibitor. In this case,
we applied a modified form of the Stern-Volmer equation (2)
where fa is an accessible fraction of fluorochromes. From equation
(2), the accessible fraction of DDUFRpfB tryptophanes for
compound (VII) (fa) was close to 65%. These results were
compared with quenching of DDUFRpfB by iodide which interacts
with the exposed fluorochromes only [26]. Similar to the NPT
Table 1. Influence of NPT compounds on growth of some actinobacteria and on muralytic activity of Rpfs.
Compound Chemical name MIC M. luteus, mg/ml
4-MUF-3-NAG hydrolysis IC50
mg/ml
Rpf Sm DDUF Rpf B
I 4-Methoxy-5-nitro-6-thiocyanatopyrimidine NI 5.361.7 ND
II 4-Isopropylamino-5-nitro-6-thiocyanatopyrimidine NI NI NI
III 1,5-Dinitro-2,4-dithiocyanatobenzene 5 1.260.7 0.4560.15
IV 2-Nitro-4-(trifluoromethyl)phenyl thiocyanate 5 5.361.4 ND
V 3-Nitro-4-thiocyanobenzonitryl 1–5 5.261.1 4.662.6
VI 4-Acetyl-2-nitrophenyl thiocyanate 5 2.261.3 1.360.7
VII 4-Benzoyl-2-nitrophenyl thiocyanate 1–5 1.960.9 1.561.3
VIII 3-Nitro-4-thiocyanatobenzoic acid NI NI NI
IX 3-Nitro-4-thiocyanatobenzoic acid methyl ester 5–10 5.661.5 0.560.1
X 3-Nitro-4-thiocyanato-benzoic acid ethyl ester 10 2.661.1 ND
MIC is defined as the lowest concentration which suppresses the growth of bacteria. The experiment was repeated 5 times for M. luteus; 2 times for M. smegmatis and 3
times for M. tuberculosis.M I C sf o rM. luteus and M. smegmatis were determined during 24 hours; for M. tuberculosis – 8 days.
KI50 was examined for RpfSm 5 times and 3 times for DDUFRpfB. ND – not done. NI – no inhibition was observed.
doi:10.1371/journal.pone.0008174.t001
Figure 2. Fluorescence quenching of DDUFRpf B. A. quenching by (VII). DDUFRpf B was dissolved in 50 mM phosphate buffer pH 7.5 at
concentration 40 mg/ml. Results were shown in the Stern–Volmer plot and in the modified Stern–Volmer plot (insert). Excitation - 280 nm,
fluorescence intensity was recordered at 340 nm. Experiment was performed 2 times, with similar results. One experiment is shown. B. quenching by
KI. For details see legend to Fig. 2A. Experiment was performed 2 times, with similar results. One experiment is shown.
doi:10.1371/journal.pone.0008174.g002
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(Figure 2B); however, the accessible fraction in this case was
estimated close to 40%. Because the DDUFRpfB molecule contains
5 tryptophan residues (the major contributors in an auto-
fluorescence under excitation used), 65% of accessibility to (VII)
corresponds to three tryptophanes. 40% accessibility for iodide
corresponds two exposed tryptophan residues localized on the
molecule surface, indicating that the substance (VII) interacted
with at least two exposed and one buried tryptophan. Note, that in
case of inactive compound (VIII) the accessible fraction was
similar to iodide (not shown).
Biological Activity of the NPT Compounds
The biological effect of the NTP compounds was studied in
three different Rpf-producing bacteria, such as M. luteus, M.
smegmatis and M. tuberculosis. M. luteus, containing the single rpf gene
essential for growth [29], is an excellent model organism for study
the inhibitors of Rpf. Seven out of ten tested compounds inhibited
M. luteus growth in the NB liquid medium (MICs were between 1-
10 mg/ml). Moreover, there was clear correlation between
inhibition of the enzymatic activity of Rpf and bacteriostatic
effects displayed by the compounds. For example, the compounds
(II) and (VIII) did not influence the Rpf enzymatic activity and had
no effect on M. luteus growth (Table 1).
However, the main known function of Rpfs is resuscitation of
dormant or ‘‘non-culturable’’ cells [15,20]. Therefore, we tested
the effect of NPT on resuscitation of dormant mycobacteria in two
dormancy models, which we had previously developed.
In the first model the majority of M. smegmatis cells lose the
ability to produce colonies on agar or grow in a liquid medium
upon incubation in prolonged stationary phase [30]. Such ‘‘non-
culturable’’ cells could be resuscitated in a liquid medium when
Rpfs added exogenously or overexpressed from a high-copy
number plasmid [20,21]. A Most Probable Number assay was
applied to estimate the number of resuscitated cells. We consider
resuscitation successful when the ratio MPN/CFU is equal or
more than 1000. As follows from Figure 3 the addition of any NTP
compound, (except (I), (II) and (VIII)), significantly suppressed
resuscitation of M. smegmatis cells. The observed inhibitory effect
was concentration dependent (Figure 4), and the most potent
compounds (III, IV, VII, IX) were active at 0.1–1 mg/ml
concentrations which did not inhibit growth of active cells of M.
smegmatis ( not shown). In the second model ‘‘non-culturable’’ cells
of M.tuberculosis resuscitate spontaneously, nevertheless this process
is Rpf-dependent since the Rpf mutants were unable to resuscitate
[6]. We found that compound (IX) and its derivatives (V-VII and
X) as well as compound (IV) at concentration 10 mg/ml increased
time which need for developing of visible growth in the MPN assay
and decreased the final values of MPN in comparison with
untreated resuscitating cells (Figure 5, Table S1). However, one of
the most potent compounds for inhibition of resuscitation of
M.smegmatis (III) practically did not influence resuscitation of
M.tuberculosis. Compounds (I,VIII) had no influence on the
resuscitation kinetics (not shown). None of the compounds tested
suppressed growth of active cells of M. tuberculosis at the same
concentration (not shown).
Discussion
The structural studies of the conserved domain of Rpf could be
considered as a ‘‘compact hybrid’’ of c-type lysozyme and lytic
transglycosylases [13,14], two classes of enzymes cleaving 1, 4-b-
glycosidic bond between N-acetylmuramic acid and N-acetylglu-
cosamine in peptidoglycan. Two inhibitors of lytic transglycosy-
lases from Gram-negative bacteria (bulgecine and NAG-thiazo-
line) were reported, but they have never been tested against Gram-
positive bacteria [31,32]. Therefore, a novel class of NPT
inhibitors of the muralytic activity of Rpf opens a new way in
the study of cell-wall hydrolyzing enzymes from Gram-positive
bacteria, in particular, mycobacteria.
Through our efforts related to the search of new antimicrobial
compounds we observed that derivatives of ortho-nitrodialkyl-
dithiocarbamate have potent antimycobacterial activity [33]. As a
result of different chemical modifications of this basic structure we
Figure 3. Influence of NPT compounds on resuscitation of M.
smegmatis ‘‘non-culturable’’ cells. Resuscitation was performed by
the MPN assay (for details see ‘‘Materials and methods’’). Inhibitors were
added at 1 mg/ml to some wells. Plates were incubated for 2 weeks at
37uC with shaking, 100 rpm. CFU of the culture before resuscitation was
,5 cells/ml. Bars represent (95%) confidence limits for MPN assay. This
experiment was repeated six times using different starved cultures with
similar results. One typical experiment is shown.
doi:10.1371/journal.pone.0008174.g003
Figure 4. Influence of compound (IX) on resuscitation of ‘‘non-
culturable’’ cells of M. smegmatis. Resuscitation of ‘‘non-culturable’’
cells of M. smegmatis obtained in the stationary phase (see ‘‘Materials
and methods’’) was performed in the liquid medium by MPN assay as
described in the ‘‘Materials and methods’’. Plates with resuscitating cells
were incubated for 2 weeks at 37uC with shaking at 100 rpm. Filled
column – CFU count before resuscitation. Opened columns – MPN
counts. Concentrations of compound (IX) added to the resuscitation
medium are shown above each column. Bars represent (95%)
confidence limits for MPN and 6SD for CFU.
doi:10.1371/journal.pone.0008174.g004
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which has similar electron affinity. Using a facile synthesis of the
target we obtained several ortho nitroarylthiocyanate derivatives
(Figure 1), based on the reaction of nucleophylic substitution, the
active chloroatom in nitroaryl moiety was substituted by
thiocyanate ion.
We found that some of these compounds strongly suppressed
germination of fungal spores (unpublished). Structural similarity
between Rpf and cell wall lytic enzymes involved in spore
germination (see above) allowed us to suggest that NPTs may
influence on the activity of Rpf.
We first showed that most of candidate compounds indeed
inhibit muralytic activity of Rpf in the non-competitive mode
(Figure S1). The measurements of the fluorescence quenching
unequivocally prove a strong interaction between inhibitory NPTs
and the internal region of Rpf, providing a molecular basis for
inhibition of the enzymatic activity. Based on the published crystal
structure of DDUFRpfB [14], we suggest that the compound (VII) is
able to interact with the exposed Trp residues, 349, 285 and with
one out of three buried Trp-297,316 and 352. Because buried
Trp-316 and Trp-297 are localized closely, their accessibility to
the quencher would be similar, therefore we could suggest that
compound (VII) interacts not with these two residues but with
Trp-352 which lies in the catalytic site of the molecule [13]. From
this, interaction of the inhibitor (VII) with the catalytic site appears
plausible. The absence of significant changes in the secondary
structure of Rpf (Figure S2) ruled out a possible non-specific
inactivation of the enzyme, for example, protein aggregation,
under NPT binding. Specificity of NPT as inhibitors of Rpf
enzyme remains to be proved however, NPT did not influence the
activity of some well-known enzymes as alkoholdehydrogenase
(1.1.1.1), laccase (1.10.3.2) and trypsin (3.4.21.4) (Table S2). The
observed inhibitory effect of NPTs on growth of M. luteus is in a
good accordance of Rpf essentiality in this bacterium. Remark-
ably, we found a good correlation between the effectiveness of
different NPTs to inhibit the enzymatic activity of Rpf and to
arrest growth of M. luteus cells (with the exception of compound
(I)). The inhibitory concentration range for these compounds was
also similar for both processes.
It was stated that Rpf proteins stimulate growth of cells at
suboptimal or stressful conditions, but not of actively multiplying
cells [24]. In particular, the deletion of rpf genes did not
significantly impair the growth of the axenic cultures of M.
tuberculosis, but exhibited a vital effect on their resuscitation in the
liquid medium in vitro [5,6] or an activation of chronic infection in
vivo [8]. According to this, NPT were active against resuscitation of
‘‘non-culturable’’ cells of both M. smegmatis and M.tuberculosis but to
the less extent against the growth of viable cells, providing
additional evidence for collective non-essentiality of rpf genes in
M.tuberculosis [6]. Thus, on the basis of data obtained from several
experimental models we may conclude that 2-nitrophenylthiocya-
nates represent a first group of inhibitors of the Rpf-mediated
mycobacterium resuscitation.
Availability of derivatives of NPT with different effects against
Rpf activities provides some insight in the mechanism of their
action. So, the failure of the compound (VIII) to inhibit 4-MUF-3-
NAG hydrolyzing activity, growth of M. luteus and resuscitation of
M. smegmatis, most likely could be explained by presence the
negative charge on the molecule. Indeed, in published crystal
structure of DDUFRpfB, a negatively charged region in the catalytic
site has been established [14]. This may produce a significant
obstacle for interaction of the compound (VIII) with the catalytic
site. Indeed, according to the fluorescence studies, (VIII) doesn’t
interact with the buried tryptophanes.
Despite a rather good correlation between anti-enzymatic and
anti-resuscitation activities observed in this study, more experi-
ments are required to confirm that Rpf proteins are, indeed, the
targets for NPT in cells. The unique ability of NPT to suppress or
at least delay resuscitation of ‘‘non-culturable’’ mycobacteria
makes them attractive agents for specific target - non-replicating
mycobacteria.
Because Rpf proteins are likely important for the establishing of
chronic [7,8] and even probably acute [5] form of experimental
(mice) tuberculosis, such compounds could be prospective for
preventing of the latent tuberculosis activation or could be efficient
against active TB. The task of the future is to study an activity of
the NPT compounds in the animal experimental tuberculosis
models.
Supporting Information
Figure S1 Inhibition of 4-MUF-3-NAG hydrolysis by RpfSm in
the presence of (VII). 4-MUF-3-NAG hydrolysis by RpfSm
(30 mg/ml) was performed according to ‘‘Materials and methods’’
without inhibitor (¤) or in the presence of (VII): - 0.5 mg/ml; m -
1 mg/ml; 6-5mg/ml; *- 10 mg/ml. The Lineweaver-Burk plot
Found at: doi:10.1371/journal.pone.0008174.s001 (4.81 MB TIF)
Figure S2 Influence of compound (VII) on the secondary
structure of Rpfs. CD spectra of DDUFRpf B (A) and Rpf Sm
(B) in absence and presence of (VII) were obtained as described in
the ‘‘Materials and methods’’. Concentration of Rpf Sm was
40 mg/ml and DDUFRpf B- 60 mg/ml. Concentration of (VII)
were 2 and 4 mg/ml. Inhibitor was dissolved in acetonitrile. The
spectra were recorded from 195 to 260 nm and the average of
three wavelength scans is presented.
Found at: doi:10.1371/journal.pone.0008174.s002 (5.81 MB TIF)
Table S1 Influence of NPT compounds on resuscitation of M.
tuberculosis ‘‘non-culturable’’ cells obtained in vitro. Confidence
Figure 5. Influence of NPT compounds on resuscitation of M.
tuberculosis ‘‘non-culturable’’ cells obtained in vitro. ‘‘Non-
culturable’’ cells of M. tuberculosis cultures were obtained after cell
cultivation during 50 days in Sauton’s medium without K
+. Resuscitation
was performed in the absence or presence of inhibitors at 10 mg/ml
using 10-fold serial dilutions (MPN assay). MPN values were counted
periodically during resuscitation time until their stabilization.
doi:10.1371/journal.pone.0008174.g005
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logarithmic transformation of cell concentration (cells/ml) esti-
mated by MPN assay. The ‘‘lower ‘‘ and ‘‘upper’’ values are
logarithmic transformation of cell concentrations representing
95% confidence limits of the assay.
Found at: doi:10.1371/journal.pone.0008174.s003 (0.04 MB
DOC)
Table S2 Influence of compounds (III) and (VII) on activity of
some enzymes t1/2- time is needed to achieve a 50% level of
substrate conversion. Alcoholdehydrohenase(1.1.1.1) activity: ADH was
dissolved in 50 mM phospahe buffer pH 7 at the concentration
10 mg/ml. The rate of the reaction was judged by transformation
of NAD
+ (1 mM) into NADH+H
+. As the substrate ethanol was
used. Activity was measured by OD340. Laccase(1.10.3.2) activity:
Laccase was dissolved in the 50 mM citrate-phosphate buffer,
pH4.5 at concentration 9 mg/ml. Pyrocatechin was used at
concentration 11 mg/ml. Activity was measured by OD410.
Trypsin(3.4.21.4) activity: The enzyme at concentration 8.0 mg/ml
was dissolved in 50 mM Tris-HCl buffer pH 8.0. Concentration of
the substrate (N-CBz-Gly-Gly-Arg-b-naphthylamide - Sigma-
Aldrich)- 11 mg/ml. Registration of the kinetic curves was made
fluorimetrically - excitation wavelength - 330 nm; emission -
420 nm.
Found at: doi:10.1371/journal.pone.0008174.s004 (0.02 MB
DOC)
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